New Zealand markets open in 7 hours 28 minutes

Gilead Sciences, Inc. (GILD)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
64.29+1.97 (+3.16%)
As of 09:32AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 79.05B
Enterprise value 99.60B
Trailing P/E 19.29
Forward P/E 9.68
PEG ratio (5-yr expected) 0.54
Price/sales (ttm)2.89
Price/book (mrq)3.91
Enterprise value/revenue 3.62
Enterprise value/EBITDA 11.55

Trading information

Stock price history

Beta (5Y monthly) 0.33
52-week change 3-7.54%
S&P500 52-week change 3-15.36%
52-week high 374.12
52-week low 357.17
50-day moving average 363.34
200-day moving average 363.50

Share statistics

Avg vol (3-month) 36.84M
Avg vol (10-day) 37.56M
Shares outstanding 51.25B
Implied shares outstanding 6N/A
Float 81.25B
% held by insiders 10.09%
% held by institutions 182.02%
Shares short (14 Sept 2022) 416.69M
Short ratio (14 Sept 2022) 42.26
Short % of float (14 Sept 2022) 41.33%
Short % of shares outstanding (14 Sept 2022) 41.33%
Shares short (prior month 14 Aug 2022) 417.04M

Dividends & splits

Forward annual dividend rate 42.92
Forward annual dividend yield 44.73%
Trailing annual dividend rate 32.88
Trailing annual dividend yield 34.62%
5-year average dividend yield 43.76
Payout ratio 488.07%
Dividend date 328 Sept 2022
Ex-dividend date 413 Sept 2022
Last split factor 22:1
Last split date 327 Jan 2013

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Jun 2022

Profitability

Profit margin 15.04%
Operating margin (ttm)40.36%

Management effectiveness

Return on assets (ttm)10.61%
Return on equity (ttm)20.58%

Income statement

Revenue (ttm)27.52B
Revenue per share (ttm)21.92
Quarterly revenue growth (yoy)0.70%
Gross profit (ttm)21.78B
EBITDA 13.21B
Net income avi to common (ttm)4.14B
Diluted EPS (ttm)3.27
Quarterly earnings growth (yoy)-24.80%

Balance sheet

Total cash (mrq)6.14B
Total cash per share (mrq)4.9
Total debt (mrq)26.22B
Total debt/equity (mrq)129.69
Current ratio (mrq)1.43
Book value per share (mrq)16.14

Cash flow statement

Operating cash flow (ttm)10.1B
Levered free cash flow (ttm)8.68B